Vol 3, No 2 (April 15, 2014): Translational Lung Cancer Research (the 10th Congress of Spanish Lung Cancer Group I)

Preface

Preface

Rafael Rosell, Bartomeu Massuti, Niki Karachaliou

PDF Pages: 64-65 Full Text (2497) Open Access

Review Article

10^th Congress on Lung Cancer—updates on clinical trials: goal

Rosario García Campelo, Bartomeu Massuti, Joaquín Mosquera, Rafael Rosell

PDF Pages: 66-69 Full Text (5094) Open Access

Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements

Cristina Teixidó, Niki Karachaliou, Vicente Peg, Ana Gimenez-Capitan, Rafael Rosell

PDF Pages: 70-74 Full Text (12320) Open Access

Hippo/YAP pathway for targeted therapy

Emanuela Felley-Bosco, Rolf Stahel

PDF Pages: 75-83 Full Text (17968) Open Access

Targeted therapy in NSCLC driven by HER2 insertions

Solange Peters, Stefan Zimmermann

PDF Pages: 84-88 Full Text (8502) Open Access

Mini-Review Article

Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancer

Mariano Provencio, Antonio Sánchez

PDF Pages: 89-94 Full Text (6401) Open Access

Review Article

State of the art in surgery for early stage NSCLC—does the number of resected lymph nodes matter?

Laura Romero Vielva, Manuel Wong Jaen, José A. Maestre Alcácer, Mecedes Canela Cardona

PDF Pages: 95-99 Full Text (4882) Open Access

Original Article

Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment

Ivonne Nel, Ulrich Jehn, Thomas Gauler, Andreas-Claudius Hoffmann

PDF Pages: 100-106 Full Text (7391) Open Access

Review Article

Predicting resistance by selection of signaling pathways

Niki Karachaliou, Rafael Rosell, Miguel Angel Molina, Santiago Viteri

PDF Pages: 107-115 Full Text (7288) Open Access

How old is “too old” for translational research?

Alain Vergnenegre, Romain Corre, Hervé Lena, Hervé Le Caer

PDF Pages: 116-119 Full Text (3091) Open Access

Disclosure:

The focused issue “the 10th Congress of Spanish Lung Cancer Group I” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Rafael Rosell, Bartomeu Massuti and Niki Karachaliou served as the unpaid Guest Editors for the focused issue.